TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: nightly oxygen saturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: improvement in symptom severity
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Events of acid reflux
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Acid clearance time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: 6-month pedometer steps/day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cystatin C ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Plasma lactate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: new ischemic lesions detected by DWI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: MPA AUC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: patient satisfaction with analgesia
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Recurrence rate within 1 year
Endpoint domain: Mortality/survival
Primary endpoint: Distal margin length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distance between dentate line and distal incision line
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean total morphine use in PACU
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Mean total 24 hr morphine use
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Mean total morphine used at 48 hr
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: SC-weighted mean values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: BHE total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Requirement of parenteral analgesics
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Analgesia requirements
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Peak plasma levels of TNF-alpha
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: 24-hr TNF-alpha area under the curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Volume of blood drawn and discarded
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Association between PCVs and daily ozone levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Association between PCVs and 3-day mean ozone levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Association between PCVs and daily PM2.5 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduction of test anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: reduction of school reluctance
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: reduction of attention problems
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Inhibition of HBV replication
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of YMDD mutation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in arterial blood gases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Reduction in ineffective inspiratory efforts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Duration of first remission
Endpoint domain: Mortality/survival
Primary endpoint: Average change in steps per day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 6-Minute Walk Test (6MWT) improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: composite measure of incident CAD death, ACS, or revascularization
Endpoint domain: Mortality/survival
Primary endpoint: swelling/edema/inflammation score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Healing of diabetic foot ulcers (DFUs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recurrence of previously healed DFUs
Endpoint domain: Adverse events/effects
Primary endpoint: Change in C-reactive protein levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression to WHO stage 4 or death
Endpoint domain: Mortality/survival
Primary endpoint: Magnitude of hip and knee torques
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anterior tibial shear
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-reported disability measures
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Ventilator time
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Life Years Gained (LYG)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Reduction in blood lipid indices (TC, TG, LDL-C, ET, HDL-C)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Conversion to normal glucose metabolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 2 h glucose levels in oGTT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: average time to expulsion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of pain episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: max flow rate (MFR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of strokes prevented
Endpoint domain: Mortality/survival
Primary endpoint: major wound complication rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: horizontal and vertical skeletal relapse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of Alzheimer disease
Endpoint domain: Mortality/survival
Primary endpoint: Risk of vascular dementia
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of bacteriologically confirmed active pulmonary tuberculosis
Endpoint domain: Mortality/survival
Primary endpoint: Reports of adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Creatinine phosphokinase (CK) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Time to regaining consciousness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Workload maximum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rates of episiotomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Rates of deep perineal lacerations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Rates of superficial scalp trauma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: initial smoking cessation
Endpoint domain: Mortality/survival
Primary endpoint: long-term abstinence
Endpoint domain: Mortality/survival
Primary endpoint: cost per QALY gained
Endpoint domain: Resource use
Primary endpoint: Mean postoperative value of nasolabial angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participation restriction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Activity limitation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Dyspnoea score increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Annual incidence rate of mild exacerbations
Endpoint domain: Adverse events/effects
Primary endpoint: Decrease in menopausal symptoms
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Decrease in total cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Decrease in low-density lipoprotein
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Interval between initiation of induction to active labour
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean time between initiation of induction to delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful labor induction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: p53 expression in clinically apparent AKs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: E-cadherin levels in clinically apparent AKs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiovascular fitness indices
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: degree of erythema
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: degree of scaling
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: subjective discomfort (itching, burning, stinging)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Systemic and pulmonary vascular resistance reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Central venous pressure decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Prevalence of sensitization to HDM
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Negative Peak Latency (NPL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Fetal arterial oxygen saturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive FIM change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Breastfeeding rates at 2 months
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Nasal conjunctival staining
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptoms of ocular dryness
Endpoint domain: Adverse events/effects
Primary endpoint: Mean amplitude of propagated activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Duration of propagated activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: ten-year survivorship free of aseptic revision or reoperation
Endpoint domain: Mortality/survival
Primary endpoint: rate of aseptic revisions
Endpoint domain: Adverse events/effects
Primary endpoint: Fixation failure rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Deposition of aerosol particles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Central corneal thickness decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of thrombus reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Scar width measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Vancouver Scar Scale height score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Hospital re-admission rate
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Consultation with General Medical Practitioner
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Use of social services
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Understanding of neurophysiology of pain
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Reduction of Pain Catastrophizing Scale subscale 'ruminating'
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: caregiver QOL
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: burden of patient symptoms
Endpoint domain: Life impact
Endpoint subdomain: Societal/carer burden
Primary endpoint: caregiving task burden
Endpoint domain: Life impact
Endpoint subdomain: Societal/carer burden
Primary endpoint: Shorter time of mechanical ventilation support
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Letality
Endpoint domain: Mortality/survival
Primary endpoint: fat-free mass change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Continuation of sulfasalazine therapy for at least 5 years
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Metabolic profile maintenance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Postoperative NGAL, urea and creatinine values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Underlying vascular lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Maintenance of PMM strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Deaths related to diabetes
Endpoint domain: Mortality/survival
Primary endpoint: Deterioration of retinopathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ophthalmic outcomes
Primary endpoint: Deterioration in visual acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ophthalmic outcomes
Primary endpoint: penile length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Associations between toenail Cr and cardiovascular disease (CVD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: self-reported disability scores due to back pain
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Pain Catastrophizing Scale scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Pain severity during chair rise activity and walking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 1-year disease-free survival
Endpoint domain: Mortality/survival
Primary endpoint: Survival rate of vitrified blastocysts after thawing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Degree of airway obstruction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Time to open eyes after stopping sedation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: General self-efficacy score improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: School/daycare functioning
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Fear of hypoglycaemia
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cost-effectiveness of zinc and zinc with copper supplementation
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: 9-month mortality
Endpoint domain: Mortality/survival
Primary endpoint: grade 4 adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction in computer anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Increase in computer confidence
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Increase in computer self-efficacy
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Peak Fz timing during stair descent
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ocular temperature rise
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: non-invasive tear film stability improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SF‐36 mental health score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: self-efficacy score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Contact time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plantar pressure measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cp50 for fentanyl
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cp50-BAR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: C reactive protein (CRP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical limitations in activities of daily living
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Reduction in heavy drinking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of DSWH
Endpoint domain: Adverse events/effects
Primary endpoint: expectations of lower pain
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time to Progression (TTP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: phantom limb pain reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cost-effectiveness ratios
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Neutrophil infiltration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: H. pylori density
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Risk of cardiovascular death
Endpoint domain: Mortality/survival
Primary endpoint: Mean defibrillation threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Tolerability threshold for shocks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: A1C levels reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Diabetes distress reduction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: lean tissue mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Development and maintenance of substance use or major depressive disorder
Endpoint domain: Physiological/clinical
Endpoint subdomain: Mental health outcomes
Primary endpoint: saccharine transit times
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease of at least 50% from baseline HDRS‐17 scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease of at least 50% from baseline HARS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: internal adaptation of crowns at axial wall
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: internal adaptation of crowns at occlusal surface
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative NT-proBNP level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Delayed requirement for mechanical ventilation
Endpoint domain: Adverse events/effects
Primary endpoint: Injection pain severity
Endpoint domain: Adverse events/effects
Primary endpoint: Injection pain frequency
Endpoint domain: Adverse events/effects
Primary endpoint: Range of motion of the treated segment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain reduction in neck and arm
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: birth rate per embryo transfer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Visual analog system scores greater than zero
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean globe movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pregnancy rates (PRs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of multiple pregnancy
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction in suicidal behaviours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in NSSI behaviours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvements in emotion regulation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Eczema Area and Severity Index scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean changes of the sum UPDRS parts II/III score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Development of esophageal cancer (EC) and gastric cardia cancer (GCA)
Endpoint domain: Mortality/survival
Primary endpoint: Latency in post-training consultation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Normalization of blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BALP activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Severe IVH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes